{"name":"TenNor Therapeutics Inc.","slug":"tennor-therapeutics-inc","ticker":"","exchange":"","domain":"tennor.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Bismuth potassium citrate placebo capsules","genericName":"Bismuth potassium citrate placebo capsules","slug":"bismuth-potassium-citrate-placebo-capsules","indication":"Control arm in Phase 3 clinical trial (specific indication unknown)","status":"phase_3"},{"name":"Clarithromycin placebo tablets","genericName":"Clarithromycin placebo tablets","slug":"clarithromycin-placebo-tablets","indication":"Control arm in phase 3 clinical trial (active indication unknown)","status":"phase_3"},{"name":"TNP-2092 capsules","genericName":"TNP-2092 capsules","slug":"tnp-2092-capsules","indication":"Other","status":"phase_1"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Rifasutenizol capsules","genericName":"Rifasutenizol capsules","slug":"rifasutenizol-capsules","indication":"Tuberculosis (pulmonary and extrapulmonary)","status":"phase_3"}]}],"pipeline":[{"name":"Bismuth potassium citrate placebo capsules","genericName":"Bismuth potassium citrate placebo capsules","slug":"bismuth-potassium-citrate-placebo-capsules","phase":"phase_3","mechanism":"This is a placebo formulation containing bismuth potassium citrate with no active therapeutic mechanism.","indications":["Control arm in Phase 3 clinical trial (specific indication unknown)"],"catalyst":""},{"name":"Clarithromycin placebo tablets","genericName":"Clarithromycin placebo tablets","slug":"clarithromycin-placebo-tablets","phase":"phase_3","mechanism":"This is a placebo tablet with no active pharmacological mechanism.","indications":["Control arm in phase 3 clinical trial (active indication unknown)"],"catalyst":""},{"name":"Rifasutenizol capsules","genericName":"Rifasutenizol capsules","slug":"rifasutenizol-capsules","phase":"phase_3","mechanism":"Rifasutenizol is a rifamycin-class antibiotic that inhibits bacterial RNA polymerase to prevent transcription and translation in mycobacteria.","indications":["Tuberculosis (pulmonary and extrapulmonary)","Drug-resistant tuberculosis"],"catalyst":""},{"name":"TNP-2092 capsules","genericName":"TNP-2092 capsules","slug":"tnp-2092-capsules","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQTHBvOXR0RkRqVFg5bXk4eW5QbV9jbFhsNTV1YTFfU1JRa0VlSWU0REg0Z0lScVVGWEN3NTJteE12U21YMVF0dEtVQ0JNb24yUGVTSEZtekZuV0p2QWgtYXE5YzJmM2cxR203VGx3UVZIS2x0TkRJZ2d6ZF91S1BtcmRIRmxhbUVrR3MySGJ3Zml6clhmOW1FRzdvcmFIWU0?oc=5","date":"2026-04-01","type":"pipeline","source":"openPR.com","summary":"Helicobacter Pylori Infection Treatment Market Size in the 7MM - openPR.com","headline":"Helicobacter Pylori Infection Treatment Market Size in the 7MM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOYkdnLXZvc19ITU9BSlVUa1dZMnB3dUlCbzk4TmttWWZnNW5UX21pTFlhVXVzeGRXLTRMcG95YUlzQVM1VC02b3hleWM1SGMzXzhqMVZJVEdLbk83WFF0RzhRWWx0TFZLVzVPbkVrUlN0VzEtV3NTTmFCY2JLY1ZRMnVB?oc=5","date":"2026-03-04","type":"pipeline","source":"Yahoo Finance","summary":"H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight - Yahoo Finance","headline":"H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNc2c4SkNxa2x4OXNZbjktM1VjQWlJRnZUcWp3UC03MGRoMnlvU3FlbEdyM3hxaFU0MU1OQkhXbUpQNUI3QlB2dGYwRnpCcmRXN2ZiQzZsRlVyY0ZxaFNiM2RhN08xREotbURZTU1KcjRmWDlYMnlaRV9kVE1WTWdPcEJVUy1XV01CZDYxVGJWQjJSVE1DOVZHX2hNYjNsWElZd05CcWw0bjJ1QkxNd3VNVFgzVWtwTnlwbXFBUlBLbFg1TEtlQXptRzRoaDRUeVk2Z3RTbHo1TE5YSGxYcXFPaVVGQUprU284M0JIdHpsdw?oc=5","date":"2026-01-21","type":"regulatory","source":"Citeline News & Insights","summary":"Will Chinese Firms Take More Domestically Approved FIC Drugs To The World In 2026? - Citeline News & Insights","headline":"Will Chinese Firms Take More Domestically Approved FIC Drugs To The World In 2026? - Citeline News & Insights","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNalc2Q1FaUnVObnhWaUdyTW5RNnQyaEJWRHljV2ZPd2tILUJUTXpaS1ZFMk01RHVZUFdNOUJHRjFsYzJBckJLbkd4dlQzTy1Tb0psTmJ5NzF5WUhROXQ5NlpacUhQUWkxRjhGeFpBTTdUYm1yT2V3a01xYUxacjNBRlhSekxIUXRvTFgtNFNLeEQ3ZzA0bVdkY2QzQkRPcF9BOTI2Zk85c1R3SFNtN2IyNEtwdkdXNDA?oc=5","date":"2025-08-04","type":"pipeline","source":"The Pharma Letter","summary":"TenNor eyes Hong Kong IPO to advance first-in-class antibacterial pipeline - The Pharma Letter","headline":"TenNor eyes Hong Kong IPO to advance first-in-class antibacterial pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNVG8zdFBYWFU2NFdnUDVYQk9vclhxSVNTcG9abWdmdFZ3dXB6Mk1Pb0tqSkNtNkpaWnVGZTlLa19lLWlUbTRfR0U4bzlmRlVPVUZXSFBfMVU2UG1GNV9QVFA2WjJHZHJPX0VfUnNvRmJPbTN1RDFHakpJUFI2alNkRkF5dTdWRlNYMzc5SjN4bkVPdTk0U1daci0wNlRLcHllbnVIVHZpOA?oc=5","date":"2025-02-17","type":"trial","source":"Clinical Trials Arena","summary":"Recce Pharma exceeds expectations in antibiotic skin gel trial - Clinical Trials Arena","headline":"Recce Pharma exceeds expectations in antibiotic skin gel trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxPSkoyakxTdmVBZ1NKT29tN0JXNUF4d3F6VGtoVjVqZTJUYnFfT3k2MnlrUkk4eFRTdVRqLUZ3dXZDcmNQSFYzWjl0eDItZkZLMnlsaTRyZ0hwRFQtS19ZUEtmandZcjVRV1BvQ3N1QnJNcFdPT0tzOVU3WEt1ajNnYmpab01reVY1akY5S3VUbUVieFBiV2txOEhpQ05WWUNrRFpDdVFtVE1zM2lLRWRyWVl3dFVqVzJNRjhPM2NGekdSck51SG5sODJ4WGR1aGdEWXZWOFcwb0NFNFFNbktuQTQwMWlQRTd6VURpZ1QzUEdRelgzcldvblBrdFFEdEhDV0NjX1dodjNOLU5jZlBGZkFial9KQmg5MENHSWhwRnMwU0hrNUFidGF6Qm5YVUxMaDhkV0c5ODMwbVFOUy1MTFd3?oc=5","date":"2025-01-15","type":"trial","source":"GlobeNewswire","summary":"Liver Cirrhosis Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"Liver Cirrhosis Clinical Trial Pipeline Experiences","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}